Detalles de la búsqueda
1.
Characterization of human hybrid cell line, F2N78, through a comparison of culture performances and protein qualities.
Biotechnol Lett
; 39(4): 501-509, 2017 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-28054185
2.
Effect of glucose feeding on the glycosylation quality of antibody produced by a human cell line, F2N78, in fed-batch culture.
Appl Microbiol Biotechnol
; 98(8): 3509-15, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24384750
3.
Effect of culture pH on recombinant antibody production by a new human cell line, F2N78, grown in suspension at 33.0 °C and 37.0 °C.
Appl Microbiol Biotechnol
; 97(12): 5283-91, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23553031
4.
Stable nebulization and muco-trapping properties of regdanvimab/IN-006 support its development as a potent, dose-saving inhaled therapy for COVID-19.
Bioeng Transl Med
; : e10391, 2022 Aug 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-36248234
5.
Comparable Immune Function Inhibition by the Infliximab Biosimilar CT-P13: Implications for Treatment of Inflammatory Bowel Disease.
J Crohns Colitis
; 11(5): 593-602, 2017 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28453766
6.
Characteristics of human cell line, F2N78, for the production of recombinant antibody in fed-batch and perfusion cultures.
J Biosci Bioeng
; 121(3): 317-24, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26454770
Resultados
1 -
6
de 6
1
Próxima >
>>